Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterNo recent work listed

Richard Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8709-5270; OpenAlex author ID A5009041563. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 3

  1. Targeting the IκB Kinase Enhancer and Its Feedback Circuit in Pancreatic Cancer. Co-author DOI 10.1016/j.tranon.2019.11.009↗
  2. Predictive and prognostic roles of ribonucleotide reductase M1 in resectable pancreatic adenocarcinoma. Co-author DOI 10.1002/cncr.27715↗
  3. Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer. Co-author DOI 10.1002/cncr.25883↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kazim M. Husain · 1 shared paper, 2020 · strength 0.13
  2. Domenico Coppola · 1 shared paper, 2020 · strength 0.13
  3. Sridevi Challa · 1 shared paper, 2020 · strength 0.13
  4. Mokenge Peter Malafa · 1 shared paper, 2020 · strength 0.13
  5. Surinder K. Batra · 1 shared paper, 2020 · strength 0.13
  6. Xiuli Liu · 1 shared paper, 2013 · strength 0.04
  7. Hao Xie · 1 shared paper, 2013 · strength 0.04
  8. Wei Jiang · 1 shared paper, 2013 · strength 0.04
  9. Xiulu Liu · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.